|
|
Volumn 18, Issue 1, 2003, Pages 87-89
|
|
Treatment of Parkinson's disease in Spain
|
|
Author keywords
Antiparkinsonian drugs; Parkinson's disease; Spain; Treatment
|
|
Indexed keywords
AMANTADINE;
ANTIPARKINSON AGENT;
BENSERAZIDE PLUS LEVODOPA;
BIPERIDEN;
BROMOCRIPTINE;
CARBIDOPA PLUS LEVODOPA;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENTACAPONE;
LEVODOPA;
LISURIDE;
PERGOLIDE;
PRAMIPEXOLE;
PROCYCLIDINE;
ROPINIROLE;
SELEGILINE;
TRIHEXYPHENIDYL;
CLINICAL FEATURE;
CLINICAL PRACTICE;
CONTROLLED STUDY;
DRUG USE;
HEALTH CARE SYSTEM;
HEALTH SURVEY;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICAL ASSESSMENT;
MEDICAL SPECIALIST;
MOTOR DYSFUNCTION;
PARKINSON DISEASE;
PARKINSONISM;
PATIENT INFORMATION;
PHYSICIAN ATTITUDE;
PRESCRIPTION;
PRIORITY JOURNAL;
REVIEW;
SPAIN;
STEREOTAXIC SURGERY;
ADULT;
AGED;
ANTIPARKINSON AGENTS;
CROSS-SECTIONAL STUDIES;
DRUG UTILIZATION;
FEMALE;
HEALTH SURVEYS;
HUMANS;
LEVODOPA;
MALE;
MIDDLE AGED;
PARKINSON DISEASE;
PATIENT CARE TEAM;
SPAIN;
|
|
EID: 0037246450
PISSN: 08853185
EISSN: None
Source Type: Journal
DOI: 10.1002/mds.10294 Document Type: Review |
|
Times cited : (7)
|
|
References (6)
|
